
View all data FOR FREE!
Create an account today, no credit card required.
Issue Type | XXXX |
---|---|
Country | United States |
Industry | XXXX |
Region | XXXX |
Maturity Date | 2046-11-30 |
Par Value | 2000 |
Callable | XXXX |
Next Call Date | XXXX |
Call Type | XXXX |
Call Price (%) | XXXX |
Series | XXXX |
Class | XXXX |
Maturity Structure | XXXX |
Amount Outstanding (mil) | 3250.00 |
Coupon | 4.9 |
---|---|
Coupon Type | XXXX |
Coupon Frequency | XXXX |
First Coupon Date | XXXX |
Last Coupon Date | XXXX |
Sinking Fund | XXXX |
---|---|
Security | XXXX |
Subordination | XXXX |
Debt Type | XXXX |
Issue Date | XXXX |
---|---|
Dated Date | XXXX |
Issue Size (mil) | 3250 |
Min. Piece | XXXX |
Min. Increment | XXXX |
This Abbott Laboratories corporate note has a 4.90% fixed rate coupon paid on a semi-annual basis. It was issued on November 22, 2016 with an issue size of 3250.00 million USD and matures on November 30, 2046 with a last coupon date of May 30, 2046. |
Abbott Laboratories, founded in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company dedicated to advancing health through the development of innovative products and technologies. The company operates in several segments, including nutrition, diagnostics, medical devices, and pharmaceuticals, offering a wide range of products such as baby formula, blood glucose monitoring systems, and cardiac devices.